UBS analyst Danielle Antalffy lowered the firm’s price target on Sight Sciences (SGHT) to $5 from $5.50 and keeps a Buy rating on the shares.

Mark Andersen, UBS Global Wealth Management co-head of global asset allocation, joins 'Money Movers' to discuss Wednesday's inflation data.

Kelvin Tay, Regional CIO at UBS Global Wealth Management, talks about how President-elect Trump's policy suggestions will ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 41.82% ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

On Monday, Surgery Partners Inc (SGRY) stock saw a modest uptick, ending the day at $21.25 which represents a slight increase of $0.93 or 4.58% from the prior close of $20.32. The stock opened at $ ...

There are worries some kind of dual mandate could be coming to AIMCo soon, based on comments Alberta Premier Danielle Smith has made and the ... “Canada, according to UBS, represents 2.5 per cent of ...

Such investors are advised to contact Danielle Peyton at newaction@ ... in the Company's consumer chips business. For example, UBS wrote that "[g]uidance was below even the most bearish bogeys ...

UBS Group AG has removed Credit Suisse’s signs at its one-time arch-rival’s former headquarters in Zurich, replacing them with its own. The iconic building at Paradeplatz 8 is now adorned with ...

William “Bill” Bruen Jr. and his son Andrew join an existing LPL practice after spending more than a decade at UBS. We recently compiled a list of the 10 Best European Bank Stocks to Buy ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...